Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 837 filings
- On EDGAR
- CIK 1649904
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 38
News 8 of 108
Prospectuses and Registrations 8 of 32
- S-8 Registration statement for an employee plan May 5, 2026
- S-3ASR Automatic shelf registration Feb 26, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-8 Registration statement for an employee plan Jan 16, 2026
- 424B5 Prospectus supplement for an offering Jul 10, 2025
- 424B5 Prospectus supplement for an offering Jul 9, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
- S-8 Registration statement for an employee plan Feb 29, 2024
Proxies 8 of 21
- DEFA14A Extra proxy material May 29, 2026
- DEFA14A Extra proxy material May 5, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- PRE 14A Preliminary proxy statement Apr 18, 2025
- DEFA14A Extra proxy material Aug 7, 2024
- DEFR14A Aug 7, 2024
Ownership 8 of 596
- SCHEDULE 13G Large holder reported a passive stake Oct 13, 2026
- 4 Insider reported a trade Sep 14, 2026
- 144 Notice of a proposed sale of restricted stock Sep 14, 2026
- 4 Insider reported a trade Sep 1, 2026
- 144 Notice of a proposed sale of restricted stock Aug 31, 2026
- 4 Insider reported a trade Aug 18, 2026
- 3 Insider reported their initial holding Aug 18, 2026
- 4 Insider reported a trade Aug 17, 2026
Other 8 of 42
- ARS Annual report sent to shareholders Apr 29, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- 424B7 Jul 10, 2024
- ARS Annual report sent to shareholders Apr 26, 2024
- ARS Annual report sent to shareholders Apr 27, 2023
- EFFECT Notice that a registration became effective Nov 15, 2021
- CORRESP Reply to SEC staff Nov 10, 2021
- UPLOAD Comment letter from SEC staff Nov 9, 2021
Everything here comes from Rhythm Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.